Description: Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics, QML Pathology, TML Pathology, Abbott Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories, medical centers, patient collection centers, and community imaging centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
Home Page: www.healius.com.au
161 Castlereagh Street
Sydney,
NSW
2000
Australia
Phone:
61 2 9432 9400
Officers
| Name | Title |
|---|---|
| Mr. Paul D. Anderson B.Com., C.A. | MD, CEO & Director |
| Mr. Stephen Humphries B.Sc. | CFO& Company Secretary |
| Dr. Jan Van Rooyen | Head & Group Executive of Healius Pathology |
| Ms. Paula Bayliss | Group Executive of People & Culture |
| Mr. John McKechnie | Advisor |
| Dr. Phil Lucas | Chief Executive of Lumus Imaging |
| Ian Mcphan | Chief Operating Officer of Healius Pathology |
| Sharon Ng | Head of Group FP&A |
| Mr. Arjun Narang | Group Executive of Operations Transformation |
| Mr. Jon Eide | Group Executive of Commercial & Customer |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 38.7597 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.0347 |
| Price-to-Sales TTM: | 0.4034 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 4329 |